NCT03716024View on ClinicalTrials.gov

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

PHASE2CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

July 18, 2007

Primary Completion Date

January 7, 2008

Study Completion Date

January 7, 2008

Conditions
Infectious Skin DiseaseBacterial Skin Disease
Interventions
DRUG

PTK 0796

PTK 0796 100 mg for injection; PTK 0796 capsule 100 mg

DRUG

Linezolid

Pre-mixed 600 mg IV infusion solution; Linezolid 600 mg tablets

Trial Locations (11)

46280

Paratek Recruiting Site, Indianapolis

59701

Paratek Recruiting Site, Butte

76301

Paratek Recruiting Site, Wichita Falls

76360

Paratek Recruiting Site, Electra

77074

Paratek Recruiting Site, Houston

90620

Paratek Recruiting Site, Buena Park

90716

Paratek Recruiting Site, Hawaiian Gardens

91911

Paratek Recruiting Site, Chula Vista

92056

Paratek Recruiting Site, Oceanside

92804

Paratek Recruiting Site, Anaheim

95124

Paratek Recruiting Site, San Jose

Sponsors
All Listed Sponsors
lead

Paratek Pharmaceuticals Inc

INDUSTRY